QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) An erratum has been published Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yudkoff, M. Articles by Nissim, I. Search for Related Content PubMed Articles by Yudkoff, M. Articles by Nissim, I.

---

4th Amino Acid Assessment Workshop

Brain Amino Acid Requirements and Toxicity: The Example of Leucine^1,2

Children’s Hospital of Philadelphia, Division of Child Development, Rehabilitation and Metabolic Disease, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

³To whom correspondence should be addressed. E-mail: yudkoff{at}email.chop.edu.

Glutamic acid is an important excitatory neurotransmitter of the brain. Two key goals of brain amino acid handling are to maintain a very low intrasynaptic concentration of glutamic acid and also to provide the system with precursors from which to synthesize glutamate. The intrasynaptic glutamate level must be kept low to maximize the signal-to-noise ratio upon the release of glutamate from nerve terminals and to minimize the risk of excitotoxicity consequent to excessive glutamatergic stimulation of susceptible neurons. The brain must also provide neurons with a constant supply of glutamate, which both neurons and glia robustly oxidize. The branched-chain amino acids (BCAAs), particularly leucine, play an important role in this regard. Leucine enters the brain from the blood more rapidly than any other amino acid. Astrocytes, which are in close approximation to brain capillaries, probably are the initial site of metabolism of leucine. A mitochondrial branched-chain aminotransferase is very active in these cells. Indeed, from 30 to 50% of all -amino groups of brain glutamate and glutamine are derived from leucine alone. Astrocytes release the cognate ketoacid [-ketoisocaproate (KIC)] to neurons, which have a cytosolic branched-chain aminotransferase that reaminates the KIC to leucine, in the process consuming glutamate and providing a mechanism for the "buffering" of glutamate if concentrations become excessive. In maple syrup urine disease, or a congenital deficiency of branched-chain ketoacid dehydrogenase, the brain concentration of KIC and other branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate–aspartate shuttle and a diminished rate of protein synthesis.

KEY WORDS: • brain metabolism • leucine • glutamate • maple syrup urine disease • inborn errors of metabolism • amino acids

This article has been cited by other articles:

				C. Blouet, Y.-H. Jo, X. Li, and G. J. Schwartz Mediobasal Hypothalamic Leucine Sensing Regulates Food Intake through Activation of a Hypothalamus-Brainstem Circuit J. Neurosci., July 1, 2009; 29(26): 8302 - 8311. [Abstract] [Full Text] [PDF]

				K. A. Gust, M. Pirooznia, M. J. Quinn Jr, M. S. Johnson, L. Escalon, K. J. Indest, X. Guan, J. Clarke, Y. Deng, P. Gong, et al. Neurotoxicogenomic Investigations to Assess Mechanisms of Action of the Munitions Constituents RDX and 2,6-DNT in Northern Bobwhite (Colinus virginianus) Toxicol. Sci., July 1, 2009; 110(1): 168 - 180. [Abstract] [Full Text] [PDF]

				W. J. Zinnanti, J. Lazovic, K. Griffin, K. J. Skvorak, H. S. Paul, G. E. Homanics, M. C. Bewley, K. C. Cheng, K. F. LaNoue, and J. M. Flanagan Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease Brain, April 1, 2009; 132(4): 903 - 918. [Abstract] [Full Text] [PDF]

				W. S. A. Brusilow Is Huntington's a Glutamine Storage Disease? Neuroscientist, August 1, 2006; 12(4): 300 - 304. [Abstract] [PDF]

				J. Masson, M. Darmon, A. Conjard, N. Chuhma, N. Ropert, M. Thoby-Brisson, A. S. Foutz, S. Parrot, G. M. Miller, R. Jorisch, et al. Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J. Neurosci., April 26, 2006; 26(17): 4660 - 4671. [Abstract] [Full Text] [PDF]